NIKI 8-K 2026-08-21

Niki BioSolutions, Inc. (NIKI) 8-K dated 2026-08-21 — accession 0001213900-26-092661. This URL is the filing, not the NIKI hub.

Niki BioSolutions, Inc. (NIKI) common stock.

Niki BioSolutions, Inc. filed a 8-K on 2026-08-21. Accession 0001213900-26-092661.

Cached items: 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported NIKI revenue for 2023-12-31 was $431.4K. Net income was -$2.8M. Revenue was down 66.7% from 2022-12-31 to 2023-12-31.

Not investment advice. The NIKI SEC hub lists recent forms. The stock page is the research view.